References
Herrmann N, Lanctot KL. Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned? Drug Saf. 2006;29(10):833–43.
Gebhardt S, Haberhausen M, Heinzel-Gutenbrunner M, Gebhardt N, Remschmidt H, Krieg J, et al. Antipsychotic-induced body weight gain: predictors and a systematic categorization of the long-term weight course. J Psychiatr Res. 2009;43(6):620–6.
UCSF Clinical and Translational Science Institute. Correlation sample size. San Francisco: UCSF Clinical and Translational Science Institute; 2017. http://www.sample-size.net/correlation-sample-size/. Accessed 12 Mar 2017.
Yeung EYH, Chun S, Douglass A, Lau TE. Effect of atypical antipsychotics on body weight in geriatric psychiatric inpatients. SAGE Open Med. 2017;5:2050312117708711.
Gazewood JD, Mehr DR. Diagnosis and management of weight loss in the elderly. J Fam Pract. 1998;47(1):19–25.
Schiffman SS. Taste and smell losses in normal aging and disease. JAMA. 1997;278(16):1357–62.
Author information
Authors and Affiliations
Contributions
EYHY was the principal investigator.
Corresponding author
Ethics declarations
Funding
No sources of funding were used to conduct this study.
Ethical approval
The study was approved by the Lancashire Care Trust Audit Department (no identification code given).
Conflict of interest
Eugene Y.H. Yeung and Kurt Buhagiar declared no competing conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Yeung, E.Y.H., Buhagiar, K. Correlation of Age and Metabolic Adverse Effects of Antipsychotics. Clin Drug Investig 38, 381–384 (2018). https://doi.org/10.1007/s40261-017-0607-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-017-0607-z